Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- NIDCR Notice of Participation in PAR-23-182 "Accelerating Behavioral and Social Science Through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed)"
(NOT-DE-23-015)
National Institute of Dental and Craniofacial Research
- Notice of Pre-Application Webinar for the Investigator-Initiated Research in Genomics and Health Equity: RFA-HG-23-017 (R01 Clinical Trial Optional) and RFA-HG-23-018 (R21 Clinical Trial Optional)
(NOT-HG-23-049)
National Human Genome Research Institute
- Notice of Availability: Proposed Amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)
(NOT-OD-23-162)
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of Change to Application Due Date and Instruction in Section IV in RFA-DA-24-007, "Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)"
(NOT-DA-23-032)
National Institute on Drug Abuse
- Notice of NICHD Participation in PAR-23-122: "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"
(NOT-HD-23-024)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Changes to RFA-HL-24-010 "The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)"
(NOT-HL-23-101)
National Heart, Lung, and Blood Institute
- Notice of Change to RFA-HL-24-011 "The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)"
(NOT-HL-23-105)
National Heart, Lung, and Blood Institute
- Notice of Early Termination of PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
(NOT-NS-23-103)
National Institute of Neurological Disorders and Stroke
- Notice of Early Termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
(NOT-NS-23-104)
National Institute of Neurological Disorders and Stroke
- Notice of Change to Award Budget for RFA-NS-21-029, "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
(NOT-NS-23-105)
National Institute of Neurological Disorders and Stroke
- Notice of Correction to Other Submission Requirements and Information in PAR-22-181 "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
(NOT-NS-23-106)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established cohorts (R01 Clinical Trial Optional)
(NOT-HL-23-102)
National Heart, Lung, and Blood Institute
Funding Opportunities
- NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
(PAR-23-229)
National Institute on Drug Abuse
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
- NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-23-242)
National Cancer Institute
- NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-23-243)
National Cancer Institute
- Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
(PAR-23-245)
National Library of Medicine
National Institute of Mental Health
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
(PAR-23-249)
National Institute on Alcohol Abuse and Alcoholism
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
(PAR-23-250)
National Institute on Alcohol Abuse and Alcoholism
- Alcohol Health Services Research (R01 Clinical Trial Optional)
(PAR-23-251)
National Institute on Alcohol Abuse and Alcoholism
- Alcohol Health Services Research (R34 Clinical Trial Optional)
(PAR-23-252)
National Institute on Alcohol Abuse and Alcoholism
- Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
(PAR-23-256)
National Center for Complementary and Integrative Health
National Institute on Aging
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
(PAR-23-259)
National Cancer Institute
- Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
(PAR-23-264)
National Cancer Institute
- Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
(PAR-23-273)
National Cancer Institute
- Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed)
(RFA-AG-24-028)
National Institute on Aging
- Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed)
(RFA-AG-24-029)
National Institute on Aging
- Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
(RFA-AG-24-041)
National Institute on Aging
- Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)
(RFA-AG-24-045)
National Institute on Aging
- Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed)
(RFA-NS-24-006)
National Institute of Neurological Disorders and Stroke
- Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed)
(RFA-NS-24-007)
National Institute of Neurological Disorders and Stroke
- HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
(RFA-NS-24-021)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).